Author name: Ashley Owen

Racial disparities in U.S. healthcare – part 1 Outline In this blog, we will cover: Introduction Certain diseases disproportionately affect […]

Drug shortages in the United States have become increasingly prevalent and remain a critical issue. In the first quarter of

The Rising Costs of Chronic Inflammatory Disease Treatments The increase in chronic inflammatory disease (CID) costs has been primarily driven

Diabetes tops the list of highest traditional drug spend. Diabetes spend is predominantly driven by glucagon-like peptide-1 (GLP-1) utilization, which is projected to

Last updated: May 7, 2025 Our formulary list is changing this year. We are moving to a biosimilar for Stelara®,

Join us for our new series, AI in healthcare. Learn how AI can make a positive impact on different areas

The Food and Drug Administration (FDA) approved 50 novel drugs in 2024, 5 less than the amount approved in 2023.

As we step into 2025, health systems are at a pivotal juncture with innovation and adaptability shaping their future. Here

As 2025 begins, PBMs should not be surprised to see many of the same trends they encountered last year. What’s